NeoGenomics to Participate in Upcoming Investor Conferences
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
NeoGenomics Reports Third Quarter 2025 Results
New York, NY
